WAT Institutional Holders and 13F Ownership
Compare 12 tracked holders of WAT, their reported positions and disclosed changes. Coverage is limited to the investors tracked by Whale Analyzer; these records do not establish all shareholders or current trades. Available original SEC filings for tracked 13F holders are linked below. Top tracked holders include Fundsmith Equity Fund, Viking Global Investors, First Eagle Investment Management, and Capital Research Global Investors.
Continue to the live WAT dashboardTop holders
| Investor | Reported value | Shares | Change | Report date |
|---|---|---|---|---|
| Fundsmith Equity Fund 13F holdings | $852.7M | 2.3M | Reduced | 2026-06-30 |
| Viking Global Investors 13F holdings | $623.4M | 1.7M | Increased | 2026-06-30 |
| First Eagle Investment Management 13F holdings | $500.7M | 1.3M | Reduced | 2026-06-30 |
| Capital Research Global Investors 13F holdings | $134.3M | 358.2K | New | 2026-06-30 |
| First Pacific Advisors 13F holdings | $100.6M | 268.2K | Increased | 2026-06-30 |
| AKO Capital 13F holdings | $76.3M | 203.4K | Reduced | 2026-06-30 |
| National Pension Service 13F holdings | $63.3M | 168.8K | Increased | 2026-06-30 |
| OrbiMed Advisors 13F holdings | $15.1M | 40.3K | New | 2026-06-30 |
| PRIMECAP Management Company 13F holdings | $14.5M | 38.6K | Reduced | 2026-06-30 |
| Jensen Investment Management 13F holdings | $14.5M | 38.6K | Reduced | 2026-06-30 |
| Oakmark Funds 13F holdings | $6.9M | 18.4K | Reduced | 2026-06-30 |
| Mairs & Power Funds 13F holdings | $359.7K | 959 | Increased | 2026-06-30 |
Original SEC filing sources
These recorded filings support the tracked 13F rows included in the aggregate reported values on this page. See each holder profile for source coverage and context for other disclosure types.
- Fundsmith Equity Fund SEC filing (0001569205-26-000012) · report date 2026-06-30
- Viking Global Investors SEC filing (0001103804-26-000006) · report date 2026-06-30
- First Eagle Investment Management SEC filing (0001325447-26-000033) · report date 2026-06-30
- Capital Research Global Investors SEC filing (0001422848-26-000094) · report date 2026-06-30
- First Pacific Advisors SEC filing (0001377581-26-000007) · report date 2026-06-30
- AKO Capital SEC filing (0001376879-26-000006) · report date 2026-06-30
- National Pension Service SEC filing (0001193125-26-347818) · report date 2026-06-30
- OrbiMed Advisors SEC filing (0001172661-26-003740) · report date 2026-06-30
- PRIMECAP Management Company SEC filing (0000763212-26-000028) · report date 2026-06-30
- Jensen Investment Management SEC filing (0001171200-26-000010) · report date 2026-06-30
- Oakmark Funds SEC filing (0000813917-26-000042) · report date 2026-06-30
- Mairs & Power Funds SEC filing (0001172661-26-003496) · report date 2026-06-30
Tracked-sample concentration
Reported position value for WAT is highly concentrated within this tracked-holder sample. These percentages are not market-wide ownership shares.
- Largest tracked holder: 35.5% of aggregate reported value in this sample
- Top 5 tracked holders: 92.1% of aggregate reported value in this sample
- Top 10 tracked holders: 99.7% of aggregate reported value in this sample
Whale activity this quarter
Across 12 tracked holders, 6 reduced, 6 increased. Net positioning is net selling.
- Fundsmith Equity Fund ($852.7M) (▼ 29.2% qoq shares)
- Viking Global Investors ($623.4M) (▲ 32.3% qoq shares) · modeled avg cost estimate $296.42
- First Eagle Investment Management ($500.7M) (▼ 15.2% qoq shares)
- Capital Research Global Investors ($134.3M) · modeled avg cost estimate $292.13
- First Pacific Advisors ($100.6M) (▲ 0.3% qoq shares)
- AKO Capital ($76.3M) (▼ 75.1% qoq shares)
- National Pension Service ($63.3M) (▲ 0.9% qoq shares) · modeled avg cost estimate $199.75
- OrbiMed Advisors ($15.1M) · modeled avg cost estimate $292.13
Modeled cost estimate vs current price
The share-weighted modeled cost estimate across 4 covered tracked holders is $288.33 versus a current price of $457.60, so WAT trades above that estimate (+58.7%). This model does not establish any filer's actual purchase price, unrealized gain, or investment return.
Sector positioning — Health Care
WAT sits within the Health Care sector alongside 253 other tracked names. Compare reported positions across tracked peers:
How to use this page
Values are reported public positions from tracked 13F filers and disclosures — not real-time or market-wide ownership totals. Open the live WAT dashboard for price charts and cross-investor scans, or read the SEC 13F guide.
Related stock holder pages
- MAR whale holders — MARRIOTT INTL INC NEW
- SYK whale holders — STRYKER CORPORATION
- V whale holders — VISA INC
- UBER whale holders — UBER TECHNOLOGIES INC
- MA whale holders — MASTERCARD INCORPORATED
- GOOGL whale holders — ALPHABET INC
- CHD whale holders — CHURCH & DWIGHT CO INC
- PG whale holders — PROCTER & GAMBLE CO
Learn more in Whale Analyzer Academy
Deepen your read on WAT with these Whale Analyzer Academy guides:
Frequently asked questions
Who owns WAT stock?
Whale Analyzer tracks 12 public-disclosure holders of WAT with a combined reported value of $2.40B. See the holder table above for the largest tracked positions.
Which top funds are buying WAT?
Tracked holders were net selling last quarter — 6 reduced, 6 increased. Check the "Change" column: "New" = fresh position, "Increased" = added, "Reduced" = trimmed.
How concentrated is the tracked WAT sample?
The top five tracked holders account for 92.1% of aggregate reported value in this tracked sample. This is not a market-wide ownership percentage.
How does WAT compare with the modeled cost estimate?
The share-weighted modeled cost estimate across 4 covered tracked holders is $288.33 versus a current price of $457.60 (+58.7%). It is not an actual purchase price, unrealized gain, or investment return.
What does 13F ownership mean for WAT?
These are historical reported positions from tracked filers, not real-time ownership or a complete shareholder register. Use the interactive WAT dashboard to explore them, or read our 13F Alpha Signals Guide.